Published Date: 03 Nov 2023
Germany: Science and technology corporation Merck has declared a strategic alliance with Jiangsu Hengrui Pharmaceuticals Co. Limited. Then.
Read Full NewsHome visits — once common and now resurging — flip the dynamic, as the clinician becomes a guest in the patient's home. Experts say as both learn more about each other than is possible in-office, trust can build.
Higher body fat percentage, rather than BMI, is associated with reduced sperm count and disrupted reproductive hormone levels in men.
Standard TKI doses are often too high for long-term care. Dr Mark Kris shares his strategy for smart dose reductions that protect patient outcomes.
Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.
Direct primary care is more than medicine. Dr Rajdeep Dhami shares what physicians should know before starting DPC, from operations and branding to boundaries and community.
1.
Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC
2.
Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer
3.
Global warming could be driving up women's cancer risk, find researchers
4.
Universal screening approach achieves a comparable detection rate of lung cancer
5.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
1.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
2.
Early Detection of Breast Cancer: Signs, Symptoms, and Screening Methods
3.
Understanding Extramammary Paget's Disease: Causes, Symptoms and Treatment Options
4.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
5.
Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
2.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
3.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
4.
Navigating the Complexities of Ph Negative ALL - Part IV
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation